Frederik Oudshoorn
Papers
3
Total Citations
44
H-Index
3
About
Frederik Oudshoorn is a leading clinical researcher in the field of urologic oncology, with a primary focus on advancing the management of prostate cancer through molecular imaging. His work centers on the clinical application of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT), particularly in the settings of biochemical recurrence and primary staging. Oudshoorn’s major contributions include demonstrating that PSMA PET/CT-guided salvage radiation therapy is associated with improved oncological outcomes compared to conventional imaging, a finding published in a highly cited 2022 study (30 citations). He has also pioneered the development of a novel nomogram to predict outcomes of salvage therapy in patients without metastases on PSMA PET/CT, providing a practical tool for clinical decision-making. His 2024 work comparing staging modalities before radical prostatectomy further underscores the superior diagnostic accuracy of PSMA imaging. With a growing body of work that directly impacts treatment paradigms, Oudshoorn is establishing himself as a key voice in the integration of advanced imaging into prostate cancer care, helping to refine patient selection and improve therapeutic precision.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3